시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
말기 신부전(ESRD) 시장 규모, 점유율, 성장 분석, 치료별, 진단별, 최종 용도별, 지역별 시장 규모, 점유율, 성장 분석 - 산업 예측(2025-2032년)
End-Stage Renal Disease (ESRD) Market Size, Share, Growth Analysis, By Treatment (Transplant, Dialysis), By Diagnosis (Blood Test, Urine Test), By End Use, By Region - Industry Forecast 2025-2032
상품코드 : 1623849
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,893,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 9,233,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,574,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

말기 신부전(ESRD) 세계 시장 규모는 2023년 1,120억 8,000만 달러로 평가되었습니다. 2024년 1,267억 6,000만 달러에서 2032년에는 3,393억 8,000만 달러에 이르고, 예측 기간(2025-2032년) 동안 13.1%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

신부전증 시장은 만성콩팥병(CKD) 유병률 증가와 의료 기술, 특히 유지보수가 적은 투석 시스템 및 인공신장의 발전으로 인해 큰 성장세를 보이고 있습니다. 당뇨병, 고혈압, 생활습관으로 인한 CKD는 전 세계 인구의 약 10%가 앓고 있습니다. 중국이나 인도와 같은 개발도상국의 노인층은 특히 취약하며, 말기신장질환(ESRD) 발병률이 매년 5-7%씩 증가하고 있습니다. 미국에서는 약 8,000만 명의 성인이 CKD의 위험에 노출되어 있으며, CKD가 주요 사망 원인으로 밝혀졌습니다. 웨어러블 인공신장 2.0과 같은 혁신과 탄탄한 헬스케어 인프라가 시장 확대에 기여하고 있습니다. 현재 약 7,500개에 달하는 투석 클리닉 네트워크가 확대되고 있는 것도 이러한 성장세를 더욱 부추기고 있습니다.

목차

서론

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

말기신장 질환(ESRD) 시장 규모 : 치료별

말기신장 질환(ESRD) 시장 규모 : 진단별

말기신장 질환(ESRD) 시장 규모 : 최종 용도별

말기신장 질환(ESRD) 시장 규모

경쟁 정보

주요 기업 개요

결론과 추천 사항

LSH
영문 목차

영문목차

Global End-Stage Renal Disease (ESRD) Market size was valued at USD 112.08 billion in 2023 and is poised to grow from USD 126.76 billion in 2024 to USD 339.38 billion by 2032, growing at a CAGR of 13.1% during the forecast period (2025-2032).

The kidney failure market is experiencing significant growth, driven by the rising incidence of Chronic Kidney Disease (CKD) and advancements in medical technology, particularly low-maintenance dialysis systems and artificial kidneys. CKD, stemming from diabetes, hypertension, and lifestyle factors, affects roughly 10% of the global population. The elderly demographic in developing nations like China and India is particularly vulnerable, with cases of end-stage renal disease (ESRD) increasing annually by 5-7%. In the U.S., approximately 80 million adults are at risk for CKD, underscoring its status as a leading cause of mortality. Market expansion is fueled by innovations such as the Wearable Artificial Kidney 2.0 and a robust healthcare infrastructure. The growing network of dialysis clinics, now numbering around 7,500, further supports this upward trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global End-Stage Renal Disease (Esrd) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global End-Stage Renal Disease (Esrd) Market Segmental Analysis

Global End-Stage Renal Disease (ESRD) Market is segmented by treatment, diagnosis, end use and region. Based on treatment, the market is segmented into transplant and dialysis. Based on diagnosis, the market is segmented into blood test, urine test, imaging test and others. Based on end use, the market is segmented into hospitals, dialysis centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global End-Stage Renal Disease (Esrd) Market

One of the primary factors driving the global end-stage renal disease (ESRD) market is the rising incidence of chronic kidney disease (CKD), which is often linked to prevalent conditions like hypertension and diabetes. As these chronic ailments become increasingly common, a larger segment of the population is at risk of developing CKD, which can ultimately lead to ESRD. This growing patient demographic heightens the need for effective treatment modalities such as dialysis and kidney transplantation. Consequently, this heightened demand for specialized care and interventions is significantly contributing to the expansion and growth of the ESRD market on a global scale.

Restraints in the Global End-Stage Renal Disease (Esrd) Market

One significant challenge in the global End-Stage Renal Disease (ESRD) market is the restricted availability and accessibility of treatment options, particularly kidney transplantation. The demand for kidney transplants vastly overshadows the supply of compatible organs, resulting in extensive waiting lists and prolonged delays for patients in need. Furthermore, while dialysis serves as a viable treatment, it comes with its own set of obstacles, including issues related to patient adherence, high costs, and the requirement for frequent treatment sessions. These factors collectively hinder timely access to optimal care for individuals suffering from end-stage renal disease, ultimately affecting the growth of the market.

Market Trends of the Global End-Stage Renal Disease (Esrd) Market

A prominent market trend in the global end-stage renal disease (ESRD) sector is the rising prevalence of home-based dialysis treatments, which cater to patients' demands for convenience, reduced healthcare costs, and improved health outcomes. Growing preferences for modalities like peritoneal dialysis and home hemodialysis reflect a desire for increased flexibility and independence, allowing patients to undergo treatment in a familiar environment. This shift is further fueled by technological advancements, robust training initiatives, and supportive reimbursement frameworks, all of which facilitate the transition to home dialysis. Consequently, this trend is significantly propelling the growth and transformation of the ESRD market.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global End-Stage Renal Disease (ESRD) Market Size by Treatment & CAGR (2025-2032)

Global End-Stage Renal Disease (ESRD) Market Size by Diagnosis & CAGR (2025-2032)

Global End-Stage Renal Disease (ESRD) Market Size by End Use & CAGR (2025-2032)

Global End-Stage Renal Disease (ESRD) Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기